Primary care-based telemonitoring for home care patients with heart failure and chronic lung disease

Evaluation of a primary care-based telemonitoring intervention for home care patients with heart failure and chronic lung disease: a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN89041993

Enrollment

Registered

2010-04-20

Start date

2010-02-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure and chronic pulmonary disease Circulatory System Heart failure

Interventions

Intervention group: Telemonitoring will consist of daily patient self-measurements of respiratory rate, heart rate, blood pressure, transdermal oxygen saturation, weight and body temperature. Additio

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Home care patients aged over 70 years of any gender 2. Heart failure and/or chronic pulmonary disease 3. At least two hospital admissions during the previous year (with at least one of the admissions due to the above mentioned diseases)

Exclusion criteria

Exclusion criteria: 1. Residents in nursing homes 2. Paediatric patients (younger than 14 years of age) 3. Refusal to participate in the study 4. Frequent users of specialist healthcare services (i.e., rehabilitation, haemodialysis, frequent visitors to hospital day-care centres, etc.) 5. Terminal illness with life expectancy less than 6 months 6. Cognitive impairment

Design outcomes

Primary

Measure	Time frame
Measured at 3, 6, and 12 months: 1. Number and duration of hospital admissions 2. Mortality rate 3. Cost-effectiveness	—

Secondary

Measure	Time frame
Measured at 3, 6, and 12 months: 1. Number of emergency department visits 2. Number of home visits 3. Number of primary care visits 4. Number of specialist care visits 5. Number of telephone contacts 6. Number of acute heart or respiratory decompensations 7. Quality of life (EQ-5D questionnaire at baseline and after 3, 6 and 12 months of follow-up) 8. Patient and professional satisfaction with the telemonitoring technology using validated questionnaires (after 3 months of follow-up) 9. Medication changes	—

Measure

Time frame

Measured at 3, 6, and 12 months: 1. Number of emergency department visits 2. Number of home visits 3. Number of primary care visits 4. Number of specialist care visits 5. Number of telephone contacts 6. Number of acute heart or respiratory decompensations 7. Quality of life (EQ-5D questionnaire at baseline and after 3, 6 and 12 months of follow-up) 8. Patient and professional satisfaction with the telemonitoring technology using validated questionnaires (after 3 months of follow-up) 9. Medication changes

—

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 23, 2026